share_log

微創醫療：截至二零二三年十二月三十一日止年度之全年業績預告之進一步更新

MICROPORT: FURTHER UPDATE ON THE ESTIMATED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023

香港交易所 ·  Mar 26 10:13
Summary by Moomoo AI
微創醫疗科學有限公司（「微創醫疗」）於2024年3月26日發布公告，更新其截至2023年12月31日止年度之全年業績預告。該預告顯示，公司預計出現虧損，主要由於一次性及╱（或）非現金性撥備及損失增加所致。目前，微創醫疗正在準備及完成2023年全年業績，而所提供的資料基於最新未經獨立核數師或審核委員會審核或審閱的未經審計合併財務報表。公司股東及潛在投資者應留意，最終業績將於2024年3月末前公布。公司董事會呼籲股東及潛在投資者在交易股份及證券時應審慎行事。
微創醫疗科學有限公司（「微創醫疗」）於2024年3月26日發布公告，更新其截至2023年12月31日止年度之全年業績預告。該預告顯示，公司預計出現虧損，主要由於一次性及╱（或）非現金性撥備及損失增加所致。目前，微創醫疗正在準備及完成2023年全年業績，而所提供的資料基於最新未經獨立核數師或審核委員會審核或審閱的未經審計合併財務報表。公司股東及潛在投資者應留意，最終業績將於2024年3月末前公布。公司董事會呼籲股東及潛在投資者在交易股份及證券時應審慎行事。
MicroChung Medical Sciences Limited (“MicroChung Medical”) issued an announcement on March 26, 2024 updating its annual results forecast for the year ended December 31, 2023. The notice indicates that the Company expects to incur losses primarily due to one-off and/or non-cash provisions and increased losses. MicroVenture Medical is currently preparing and finalizing its 2023 annual results, and the information provided is based on the most recent unaudited consolidated financial statements that have not been audited or reviewed by an independent auditor or audit committee. Shareholders and potential investors should note that the final results will be announced by the end of March 2024. The Board of Directors urges shareholders and potential investors to exercise caution when trading stocks and securities.
MicroChung Medical Sciences Limited (“MicroChung Medical”) issued an announcement on March 26, 2024 updating its annual results forecast for the year ended December 31, 2023. The notice indicates that the Company expects to incur losses primarily due to one-off and/or non-cash provisions and increased losses. MicroVenture Medical is currently preparing and finalizing its 2023 annual results, and the information provided is based on the most recent unaudited consolidated financial statements that have not been audited or reviewed by an independent auditor or audit committee. Shareholders and potential investors should note that the final results will be announced by the end of March 2024. The Board of Directors urges shareholders and potential investors to exercise caution when trading stocks and securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more